• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌中的脂质代谢重编程

Lipid metabolism reprogramming in colorectal cancer.

作者信息

Chen Dan, Zhou Xuebing, Yan PengYu, Yang Chunyu, Li Yuan, Han Longzhe, Ren Xiangshan

机构信息

Department of Pathology & Cancer Research Center, Yanbian University Medical College, Yanji, China.

Key Laboratory of Pathobiology, Yanbian University, State Ethnic Affairs Commission, Yanji, China.

出版信息

J Cell Biochem. 2023 Jan;124(1):3-16. doi: 10.1002/jcb.30347. Epub 2022 Nov 5.

DOI:10.1002/jcb.30347
PMID:36334309
Abstract

The hallmark feature of metabolic reprogramming is now considered to be widespread in many malignancies, including colorectal cancer (CRC). Of the gastrointestinal tumors, CRC is one of the most common with a high metastasis rate and long insidious period. The incidence and mortality of CRC has increased in recent years. Metabolic reprogramming also has a significant role in the development and progression of CRC, especially lipid metabolic reprogramming. Many studies have reported that lipid metabolism reprogramming is similar to the Warburg effect with typical features affecting tumor biology including proliferation, migration, local invasion, apoptosis, and other biological behaviors of cancer cells. Therefore, studying the role of lipid metabolism in the occurrence and development of CRC will increase our understanding of its pathogenesis, invasion, metastasis, and other processes and provide new directions for the treatment of CRC. In this paper, we mainly describe the molecular mechanism of lipid metabolism reprogramming and its important role in the occurrence and development of CRC. In addition, to provide reference for subsequent research and clinical diagnosis and treatment we also review the treatments of CRC that target lipid metabolism.

摘要

代谢重编程的标志性特征目前被认为在包括结直肠癌(CRC)在内的许多恶性肿瘤中广泛存在。在胃肠道肿瘤中,CRC是最常见的肿瘤之一,具有高转移率和长潜伏期。近年来,CRC的发病率和死亡率有所上升。代谢重编程在CRC的发生和发展中也起着重要作用,尤其是脂质代谢重编程。许多研究报道,脂质代谢重编程类似于瓦伯格效应,具有影响肿瘤生物学的典型特征,包括癌细胞的增殖、迁移、局部侵袭、凋亡和其他生物学行为。因此,研究脂质代谢在CRC发生发展中的作用将增进我们对其发病机制、侵袭、转移及其他过程的理解,并为CRC的治疗提供新的方向。在本文中,我们主要描述脂质代谢重编程的分子机制及其在CRC发生发展中的重要作用。此外,为后续研究及临床诊断和治疗提供参考,我们还综述了针对脂质代谢的CRC治疗方法。

相似文献

1
Lipid metabolism reprogramming in colorectal cancer.结直肠癌中的脂质代谢重编程
J Cell Biochem. 2023 Jan;124(1):3-16. doi: 10.1002/jcb.30347. Epub 2022 Nov 5.
2
Reprogramming of lipid metabolism in cancer-associated fibroblasts potentiates migration of colorectal cancer cells.在癌症相关成纤维细胞中重新编程脂质代谢会增强结直肠癌细胞的迁移。
Cell Death Dis. 2020 Apr 23;11(4):267. doi: 10.1038/s41419-020-2434-z.
3
Therapeutic potential of melatonin in colorectal cancer: Focus on lipid metabolism and gut microbiota.褪黑素在结直肠癌中的治疗潜力:关注脂代谢和肠道微生物群。
Biochim Biophys Acta Mol Basis Dis. 2022 Jan 1;1868(1):166281. doi: 10.1016/j.bbadis.2021.166281. Epub 2021 Oct 2.
4
Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy.结直肠癌细胞及其微环境的代谢重编程:治疗意义。
Int J Mol Sci. 2021 Jun 10;22(12):6262. doi: 10.3390/ijms22126262.
5
Targeting PLA2G16, a lipid metabolism gene, by Ginsenoside Compound K to suppress the malignant progression of colorectal cancer.靶向脂质代谢基因 PLA2G16 的人参皂苷化合物 K 抑制结直肠癌细胞的恶性进展。
J Adv Res. 2021 Jun 12;36:265-276. doi: 10.1016/j.jare.2021.06.009. eCollection 2022 Feb.
6
Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling.苍术内酯 I 通过影响 AKT/mTOR 信号通路来影响代谢和干性从而抑制结直肠癌细胞增殖。
Phytomedicine. 2020 Mar;68:153191. doi: 10.1016/j.phymed.2020.153191. Epub 2020 Feb 14.
7
Recent advances microRNAs and metabolic reprogramming in colorectal cancer research.结直肠癌研究中微小RNA与代谢重编程的最新进展。 (原英文文本表述有误,正确的应该是“Recent advances in microRNAs and metabolic reprogramming in colorectal cancer research.” )
Front Oncol. 2023 Jul 27;13:1165862. doi: 10.3389/fonc.2023.1165862. eCollection 2023.
8
Role of glucose metabolic reprogramming in colorectal cancer progression and drug resistance.葡萄糖代谢重编程在结直肠癌进展和耐药中的作用。
Transl Oncol. 2024 Dec;50:102156. doi: 10.1016/j.tranon.2024.102156. Epub 2024 Oct 13.
9
SLC25A1 promotes tumor growth and survival by reprogramming energy metabolism in colorectal cancer.SLC25A1 通过重塑结直肠癌的能量代谢促进肿瘤生长和存活。
Cell Death Dis. 2021 Nov 27;12(12):1108. doi: 10.1038/s41419-021-04411-2.
10
Shotgun lipidomics-based characterization of the landscape of lipid metabolism in colorectal cancer.基于 shotgun 脂质组学的结直肠癌脂质代谢全景特征分析。
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Mar;1865(3):158579. doi: 10.1016/j.bbalip.2019.158579. Epub 2019 Nov 30.

引用本文的文献

1
Crosstalk between dysregulated amino acid sensing and glucose and lipid metabolism in colorectal cancer.结直肠癌中失调的氨基酸感知与葡萄糖和脂质代谢之间的相互作用。
Front Oncol. 2025 Aug 29;15:1665056. doi: 10.3389/fonc.2025.1665056. eCollection 2025.
2
FASN promotes the stemness of cancer stem cells and protects colorectal cancer cells from ferroptosis by inhibiting the activation of SREBP2.脂肪酸合酶(FASN)通过抑制固醇调节元件结合蛋白2(SREBP2)的激活来促进癌症干细胞的干性,并保护结肠直肠癌细胞免受铁死亡。
Front Immunol. 2025 Aug 18;16:1611375. doi: 10.3389/fimmu.2025.1611375. eCollection 2025.
3
Liquid-liquid phase separation of GPS2-LATS1 promotes colorectal cancer progression by reprogramming lipid metabolism.
GPS2-LATS1的液-液相分离通过重编程脂质代谢促进结直肠癌进展。
Oncogene. 2025 Jul 25. doi: 10.1038/s41388-025-03498-7.
4
Identification and evaluation of metabolic mRNAs and key miRNAs in colorectal cancer liver metastasis.结直肠癌肝转移中代谢性mRNA和关键miRNA的鉴定与评估
Cancer Cell Int. 2025 Jul 16;25(1):265. doi: 10.1186/s12935-025-03903-x.
5
IGF2BP3/ESM1/KLF10/BECN1 positive feedback loop: a novel therapeutic target in ovarian cancer via lipid metabolism reprogramming.IGF2BP3/ESM1/KLF10/BECN1正反馈回路:通过脂质代谢重编程成为卵巢癌的新型治疗靶点。
Cell Death Dis. 2025 Apr 17;16(1):308. doi: 10.1038/s41419-025-07571-7.
6
FASN promotes lipid metabolism and progression in colorectal cancer via the SP1/PLA2G4B axis.脂肪酸合酶通过SP1/PLA2G4B轴促进结直肠癌中的脂质代谢和进展。
Cell Death Discov. 2025 Mar 28;11(1):122. doi: 10.1038/s41420-025-02409-9.
7
Deciphering the metabolic landscape of colorectal cancer through the lens of AhR-mediated intestinal inflammation.通过芳烃受体介导的肠道炎症视角解读结直肠癌的代谢格局。
Discov Oncol. 2025 Mar 7;16(1):275. doi: 10.1007/s12672-025-01949-x.
8
Innovative approaches in colorectal cancer screening: advances in detection methods and the role of artificial intelligence.结直肠癌筛查的创新方法:检测方法的进展及人工智能的作用
Therap Adv Gastroenterol. 2025 Jan 31;18:17562848251314829. doi: 10.1177/17562848251314829. eCollection 2025.
9
Natural Products and Derivatives Targeting Metabolic Reprogramming in Colorectal Cancer: A Comprehensive Review.靶向结直肠癌代谢重编程的天然产物及其衍生物:综述
Metabolites. 2024 Sep 9;14(9):490. doi: 10.3390/metabo14090490.
10
The lipid-metabolism enzyme ECI2 reduces neutrophil extracellular traps formation for colorectal cancer suppression.脂质代谢酶 ECI2 可减少中性粒细胞胞外诱捕网的形成,从而抑制结直肠癌。
Nat Commun. 2024 Aug 21;15(1):7184. doi: 10.1038/s41467-024-51489-1.